The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Drugs for Traveler's Diarrhea Market Research Report 2024
Synopsis
The global Drugs for Traveler's Diarrhea market was valued at US$ 785.4 million in 2023 and is anticipated to reach US$ 1159.1 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drugs for Traveler's Diarrhea, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Traveler's Diarrhea.
Report Scope
The Drugs for Traveler's Diarrhea market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drugs for Traveler's Diarrhea market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drugs for Traveler's Diarrhea manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Salix Pharmaceuticals
Chiesi Farmaceutici
Cosmo Pharmaceuticals
Nippon Shinyaku
Prokarium Limited
Scandinavian Biopharma
Sigmoid Pharma
Segment by Type
Anti-motility agents
Bismuth Subsalicylate (Pepto-Bismol)
Antibiotics
Segment by Application
Adult
Children
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drugs for Traveler's Diarrhea manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drugs for Traveler's Diarrhea in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Drugs for Traveler's Diarrhea market was valued at US$ 785.4 million in 2023 and is anticipated to reach US$ 1159.1 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drugs for Traveler's Diarrhea, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Traveler's Diarrhea.
Report Scope
The Drugs for Traveler's Diarrhea market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drugs for Traveler's Diarrhea market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drugs for Traveler's Diarrhea manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Salix Pharmaceuticals
Chiesi Farmaceutici
Cosmo Pharmaceuticals
Nippon Shinyaku
Prokarium Limited
Scandinavian Biopharma
Sigmoid Pharma
Segment by Type
Anti-motility agents
Bismuth Subsalicylate (Pepto-Bismol)
Antibiotics
Segment by Application
Adult
Children
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drugs for Traveler's Diarrhea manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drugs for Traveler's Diarrhea in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Drugs for Traveler's Diarrhea Market Overview
1.1 Product Overview and Scope of Drugs for Traveler's Diarrhea
1.2 Drugs for Traveler's Diarrhea Segment by Type
1.2.1 Global Drugs for Traveler's Diarrhea Market Value Comparison by Type (2024-2030)
1.2.2 Anti-motility agents
1.2.3 Bismuth Subsalicylate (Pepto-Bismol)
1.2.4 Antibiotics
1.3 Drugs for Traveler's Diarrhea Segment by Application
1.3.1 Global Drugs for Traveler's Diarrhea Market Value by Application: (2024-2030)
1.3.2 Adult
1.3.3 Children
1.4 Global Drugs for Traveler's Diarrhea Market Size Estimates and Forecasts
1.4.1 Global Drugs for Traveler's Diarrhea Revenue 2019-2030
1.4.2 Global Drugs for Traveler's Diarrhea Sales 2019-2030
1.4.3 Global Drugs for Traveler's Diarrhea Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Drugs for Traveler's Diarrhea Market Competition by Manufacturers
2.1 Global Drugs for Traveler's Diarrhea Sales Market Share by Manufacturers (2019-2024)
2.2 Global Drugs for Traveler's Diarrhea Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Drugs for Traveler's Diarrhea Average Price by Manufacturers (2019-2024)
2.4 Global Drugs for Traveler's Diarrhea Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drugs for Traveler's Diarrhea, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drugs for Traveler's Diarrhea, Product Type & Application
2.7 Drugs for Traveler's Diarrhea Market Competitive Situation and Trends
2.7.1 Drugs for Traveler's Diarrhea Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Drugs for Traveler's Diarrhea Players Market Share by Revenue
2.7.3 Global Drugs for Traveler's Diarrhea Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Drugs for Traveler's Diarrhea Retrospective Market Scenario by Region
3.1 Global Drugs for Traveler's Diarrhea Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Drugs for Traveler's Diarrhea Global Drugs for Traveler's Diarrhea Sales by Region: 2019-2030
3.2.1 Global Drugs for Traveler's Diarrhea Sales by Region: 2019-2024
3.2.2 Global Drugs for Traveler's Diarrhea Sales by Region: 2025-2030
3.3 Global Drugs for Traveler's Diarrhea Global Drugs for Traveler's Diarrhea Revenue by Region: 2019-2030
3.3.1 Global Drugs for Traveler's Diarrhea Revenue by Region: 2019-2024
3.3.2 Global Drugs for Traveler's Diarrhea Revenue by Region: 2025-2030
3.4 North America Drugs for Traveler's Diarrhea Market Facts & Figures by Country
3.4.1 North America Drugs for Traveler's Diarrhea Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Drugs for Traveler's Diarrhea Sales by Country (2019-2030)
3.4.3 North America Drugs for Traveler's Diarrhea Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Drugs for Traveler's Diarrhea Market Facts & Figures by Country
3.5.1 Europe Drugs for Traveler's Diarrhea Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Drugs for Traveler's Diarrhea Sales by Country (2019-2030)
3.5.3 Europe Drugs for Traveler's Diarrhea Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drugs for Traveler's Diarrhea Market Facts & Figures by Country
3.6.1 Asia Pacific Drugs for Traveler's Diarrhea Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Drugs for Traveler's Diarrhea Sales by Country (2019-2030)
3.6.3 Asia Pacific Drugs for Traveler's Diarrhea Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Drugs for Traveler's Diarrhea Market Facts & Figures by Country
3.7.1 Latin America Drugs for Traveler's Diarrhea Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Drugs for Traveler's Diarrhea Sales by Country (2019-2030)
3.7.3 Latin America Drugs for Traveler's Diarrhea Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drugs for Traveler's Diarrhea Market Facts & Figures by Country
3.8.1 Middle East and Africa Drugs for Traveler's Diarrhea Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Drugs for Traveler's Diarrhea Sales by Country (2019-2030)
3.8.3 Middle East and Africa Drugs for Traveler's Diarrhea Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Drugs for Traveler's Diarrhea Sales by Type (2019-2030)
4.1.1 Global Drugs for Traveler's Diarrhea Sales by Type (2019-2024)
4.1.2 Global Drugs for Traveler's Diarrhea Sales by Type (2025-2030)
4.1.3 Global Drugs for Traveler's Diarrhea Sales Market Share by Type (2019-2030)
4.2 Global Drugs for Traveler's Diarrhea Revenue by Type (2019-2030)
4.2.1 Global Drugs for Traveler's Diarrhea Revenue by Type (2019-2024)
4.2.2 Global Drugs for Traveler's Diarrhea Revenue by Type (2025-2030)
4.2.3 Global Drugs for Traveler's Diarrhea Revenue Market Share by Type (2019-2030)
4.3 Global Drugs for Traveler's Diarrhea Price by Type (2019-2030)
5 Segment by Application
5.1 Global Drugs for Traveler's Diarrhea Sales by Application (2019-2030)
5.1.1 Global Drugs for Traveler's Diarrhea Sales by Application (2019-2024)
5.1.2 Global Drugs for Traveler's Diarrhea Sales by Application (2025-2030)
5.1.3 Global Drugs for Traveler's Diarrhea Sales Market Share by Application (2019-2030)
5.2 Global Drugs for Traveler's Diarrhea Revenue by Application (2019-2030)
5.2.1 Global Drugs for Traveler's Diarrhea Revenue by Application (2019-2024)
5.2.2 Global Drugs for Traveler's Diarrhea Revenue by Application (2025-2030)
5.2.3 Global Drugs for Traveler's Diarrhea Revenue Market Share by Application (2019-2030)
5.3 Global Drugs for Traveler's Diarrhea Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Drugs for Traveler's Diarrhea Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Drugs for Traveler's Diarrhea Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Salix Pharmaceuticals
6.2.1 Salix Pharmaceuticals Corporation Information
6.2.2 Salix Pharmaceuticals Description and Business Overview
6.2.3 Salix Pharmaceuticals Drugs for Traveler's Diarrhea Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Salix Pharmaceuticals Drugs for Traveler's Diarrhea Product Portfolio
6.2.5 Salix Pharmaceuticals Recent Developments/Updates
6.3 Chiesi Farmaceutici
6.3.1 Chiesi Farmaceutici Corporation Information
6.3.2 Chiesi Farmaceutici Description and Business Overview
6.3.3 Chiesi Farmaceutici Drugs for Traveler's Diarrhea Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Chiesi Farmaceutici Drugs for Traveler's Diarrhea Product Portfolio
6.3.5 Chiesi Farmaceutici Recent Developments/Updates
6.4 Cosmo Pharmaceuticals
6.4.1 Cosmo Pharmaceuticals Corporation Information
6.4.2 Cosmo Pharmaceuticals Description and Business Overview
6.4.3 Cosmo Pharmaceuticals Drugs for Traveler's Diarrhea Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cosmo Pharmaceuticals Drugs for Traveler's Diarrhea Product Portfolio
6.4.5 Cosmo Pharmaceuticals Recent Developments/Updates
6.5 Nippon Shinyaku
6.5.1 Nippon Shinyaku Corporation Information
6.5.2 Nippon Shinyaku Description and Business Overview
6.5.3 Nippon Shinyaku Drugs for Traveler's Diarrhea Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Nippon Shinyaku Drugs for Traveler's Diarrhea Product Portfolio
6.5.5 Nippon Shinyaku Recent Developments/Updates
6.6 Prokarium Limited
6.6.1 Prokarium Limited Corporation Information
6.6.2 Prokarium Limited Description and Business Overview
6.6.3 Prokarium Limited Drugs for Traveler's Diarrhea Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Prokarium Limited Drugs for Traveler's Diarrhea Product Portfolio
6.6.5 Prokarium Limited Recent Developments/Updates
6.7 Scandinavian Biopharma
6.6.1 Scandinavian Biopharma Corporation Information
6.6.2 Scandinavian Biopharma Description and Business Overview
6.6.3 Scandinavian Biopharma Drugs for Traveler's Diarrhea Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Scandinavian Biopharma Drugs for Traveler's Diarrhea Product Portfolio
6.7.5 Scandinavian Biopharma Recent Developments/Updates
6.8 Sigmoid Pharma
6.8.1 Sigmoid Pharma Corporation Information
6.8.2 Sigmoid Pharma Description and Business Overview
6.8.3 Sigmoid Pharma Drugs for Traveler's Diarrhea Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sigmoid Pharma Drugs for Traveler's Diarrhea Product Portfolio
6.8.5 Sigmoid Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drugs for Traveler's Diarrhea Industry Chain Analysis
7.2 Drugs for Traveler's Diarrhea Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drugs for Traveler's Diarrhea Production Mode & Process
7.4 Drugs for Traveler's Diarrhea Sales and Marketing
7.4.1 Drugs for Traveler's Diarrhea Sales Channels
7.4.2 Drugs for Traveler's Diarrhea Distributors
7.5 Drugs for Traveler's Diarrhea Customers
8 Drugs for Traveler's Diarrhea Market Dynamics
8.1 Drugs for Traveler's Diarrhea Industry Trends
8.2 Drugs for Traveler's Diarrhea Market Drivers
8.3 Drugs for Traveler's Diarrhea Market Challenges
8.4 Drugs for Traveler's Diarrhea Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
